Halozyme Therapeutics, Inc. (BMV:HALO)

Halozyme Therapeutics Revenue

Halozyme Therapeutics had revenue of $354.26M USD in the quarter ending September 30, 2025, with 22.12% growth. This brings the company's revenue in the last twelve months to $1.24B, up 31.19% year-over-year. In the year 2024, Halozyme Therapeutics had annual revenue of $1.02B with 22.44% growth.

• Revenue (ttm): $1.24B
• Revenue Growth: +31.19%
• P/S Ratio: 5.94
• Revenue / Employee: $3.55M
• Employees: 350
• Market Cap: 135.50B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.02B	186.07M	22.44%
Dec 31, 2023	829.25M	169.14M	25.62%
Dec 31, 2022	660.12M	216.81M	48.91%
Dec 31, 2021	443.31M	175.72M	65.67%
Dec 31, 2020	267.59M	71.60M	36.53%